| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 09/02/2008 | US7419825 Propagation of neural stem cells; obtain cells, detect expression of neuronal cell markers, recover cells expressing neuronal marker, propagate cells |
| 09/02/2008 | US7419824 BASB006 polypeptides from Neisseria meningitidis and immunogenic compositions thereof |
| 09/02/2008 | US7419816 Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies and gene therapy in the CNS |
| 09/02/2008 | US7419815 Inhibitors of plant peptide deformylase for use as broad-spectrum herbicides and methods for identifying the same |
| 09/02/2008 | US7419814 Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof |
| 09/02/2008 | US7419813 Fructosyl peptide oxidase |
| 09/02/2008 | US7419807 High molecular weight; isolated nucleic acid; use in detecting antibodies in test sample; diagnostic kit |
| 09/02/2008 | US7419805 A polynucleotide encoding a carboxy-truncated interferon gamma (IFNG) polypeptide mutant exhibiting IFNG receptor binding activity having the amino acid sequence, SEQ ID NO:12, or 1-10 residue modifications; antitumor, -carcinogenic agent; viricides; interstitial lung diseases; autoimmune diseases |
| 09/02/2008 | US7419804 CASH (Caspase Homologue) with death effector domain, modulators of the function of FAS |
| 09/02/2008 | US7419800 Estrogen receptor genes |
| 09/02/2008 | US7419799 Medical diagnosis; gene expression; genetic engineering; cell proliferation |
| 09/02/2008 | US7419793 Flea octopamine receptor nucleic acid molecules, proteins and uses thereof |
| 09/02/2008 | US7419792 Detecting binding of said antigen in tissue sample; treating cells to aid in differentiation, treatment and diagnostic imaging |
| 09/02/2008 | US7419790 Sodium-independent transporter carrying acidic amino acid and its gene |
| 09/02/2008 | US7419779 Contacting compound with sumo protease polypeptide; measuring ligand or substrate binding; short interference RNA inhibits gene expression |
| 09/02/2008 | US7419777 Method and quantification assay for determining c-kit/SCF/pAKT status |
| 09/02/2008 | US7419672 Genes and proteins, and their use |
| 09/02/2008 | US7419671 For therapy and prophylaxis of Porphyromonas gingivalis infection |
| 09/02/2008 | US7419661 For use in surgical dressings where wound closure and minimal scarring is desirable |
| 09/02/2008 | US7419660 Isolating nucleic acid from malignant cells, inserting into expression vector, transformation; light regions differ by one idiotope |
| 09/02/2008 | US7419659 Nucleic acid comprising dicistronic message for producing antibody where cistron contains DNA coding heavy and light chains |
| 09/02/2008 | CA2372053C Compositions and methods for cancer treatment by selectively inhibiting vegf |
| 09/02/2008 | CA2307807C Methods and materials for the growth of primate-derived primordial stem cells in feeder-free culture |
| 09/02/2008 | CA2271244C Pressure-mediated intracellular delivery of molecules or microparticles |
| 09/02/2008 | CA2246430C Protein tyrosine phosphatases of hematopoietic cells |
| 09/02/2008 | CA2175577C Receptor on the surface of activated t-cells: acts-4 |
| 08/28/2008 | WO2008103810A1 Method of preparing lung alveolar epithelial type ii cells derived from embryonic stem cells |
| 08/28/2008 | WO2008103807A2 Methods of producing preadipocytes and increasing the proliferation of adult adipose stem/progenitor cells |
| 08/28/2008 | WO2008103746A2 Production of recombinant insulin-like growth factor-i (igf-i) and insulin-like growth factor binding protein-3 (igfbp-3) in transgenic monocots |
| 08/28/2008 | WO2008103648A1 Method of abrogating graft versus host disease via induced ship deficiency |
| 08/28/2008 | WO2008103472A2 Prevention and treatment of synucleinopathic and amyloidogenic disease |
| 08/28/2008 | WO2008103462A2 Highly efficient methods for reprogramming differentiated cells and for generating animals and embryonic stem cells from reprogrammed cells |
| 08/28/2008 | WO2008103393A1 Protein trafficking |
| 08/28/2008 | WO2008103392A2 Modulation of nkt cell activity with antigen-loaded cdid molecules |
| 08/28/2008 | WO2008103346A1 Compositions and methods for treating viral infections |
| 08/28/2008 | WO2008103290A2 Print pricing |
| 08/28/2008 | WO2008103191A1 Rnai methods and compositions for stimulating proliferation of cells with adherent junctions |
| 08/28/2008 | WO2008102937A1 Mesenchymal stem cell-mediated autologous dendritic cells with increased immunosuppression |
| 08/28/2008 | WO2008102847A1 Medical substitute membrane, use thereof, and method for repair of membrane tissue in living body |
| 08/28/2008 | WO2008102728A1 Conductive substrate for nucleic acid delivery and method for delivering nucleic acid |
| 08/28/2008 | WO2008102602A1 Organ regeneration method utilizing blastocyst complementation |
| 08/28/2008 | WO2008102557A1 Peptide vaccines for cancers expressing tumor-associated antigens |
| 08/28/2008 | WO2008102460A1 Transplantation of bone marrow stromal cell-induced neural stem cells for promoting fuctional recovery after spinal cord injury |
| 08/28/2008 | WO2008102118A1 Large scale production of stem cells |
| 08/28/2008 | WO2008102000A1 Human pancreatic beta cell lines for diagnostic of diabetes |
| 08/28/2008 | WO2008101936A1 Cells for heart treatment |
| 08/28/2008 | WO2008101350A1 Altering carotenoid profiles in plants |
| 08/28/2008 | WO2008101272A1 Method for obtaining treg-cells |
| 08/28/2008 | WO2008067142A3 In vitro differentiation of hematopoietic cells from primate embryonic stem cells |
| 08/28/2008 | WO2008063892A3 Rationally designed media for cell culture |
| 08/28/2008 | WO2008060541A3 In vitro expansion of postpartum-derived cells using microcarriers |
| 08/28/2008 | WO2008051265A3 Engineered cell growth on polymeric films and biotechnological applications there of |
| 08/28/2008 | WO2008046033A3 Enhancement of hybridoma fusion efficiencies through cell synchronization |
| 08/28/2008 | WO2008040027A3 Directed differentiation and maturation of stem cell-derived cardiomyocytes |
| 08/28/2008 | WO2008030115A3 Fluorescent cell markers |
| 08/28/2008 | WO2008027540A3 Drought-resistant plants and method for producing the plants |
| 08/28/2008 | WO2008013552A3 Fully human hybridoma fusion partner cell lines |
| 08/28/2008 | WO2008010093A3 Meganuclease variants cleaving a dna target sequence from a rag gene and uses thereof |
| 08/28/2008 | WO2007089607A3 Rna silencing agents for use in therapy and nanotransporters for efficient delivery of same |
| 08/28/2008 | WO2007081647A3 Zinc finger domains specifically binding agc |
| 08/28/2008 | WO2007078599A3 Functional arrays for high throughput characterization of gene expression regulatory elements |
| 08/28/2008 | US20080209598 Plant Cultivation Method |
| 08/28/2008 | US20080209597 Transgenic Cells Expressing Glucosyltransferase Nucleic Acids |
| 08/28/2008 | US20080209596 Plant sugar transport proteins |
| 08/28/2008 | US20080209594 Soybean Cultivar 6733322 |
| 08/28/2008 | US20080209593 Soybean cultivar 6421326 |
| 08/28/2008 | US20080209592 Soybean cultivar 6600375 |
| 08/28/2008 | US20080209591 having a mutant allele designated HSPMR which results in a powdery mildew resistant plant |
| 08/28/2008 | US20080209590 herbicide resistance; insect resistance; modified fatty acid metabolism or modified carbohydrate metabolism |
| 08/28/2008 | US20080209589 Soybean Cultivar S060077 |
| 08/28/2008 | US20080208351 Biocompatible Material for Surgical Implants and Cell Guiding Tissue Culture Surfaces |
| 08/28/2008 | US20080207776 Lipid aggregate for delivery of macromolecules into cells |
| 08/28/2008 | US20080207740 Small organic molecule regulators of cell proliferation |
| 08/28/2008 | US20080207653 Antitumor agents |
| 08/28/2008 | US20080207641 Immunosuppressants; antiallergens |
| 08/28/2008 | US20080207594 Glycogen synthase kinase inhibitor in mixture with immunomodulating agents; antidiabetic agents; immunosupprsants |
| 08/28/2008 | US20080207589 Cyclized derivatives as eg-5 inhibitors |
| 08/28/2008 | US20080207568 Class of Gamma Delta T Cells Activators and Use Thereof |
| 08/28/2008 | US20080207563 Synergistic sequential or simultaneous administration of erlotinib and a MEK inhibiting N-substituted-{2,5-dioxo-imidazolidin-1-yl}-3-phenyl-butyramide |
| 08/28/2008 | US20080207555 Catalyzing the release of ADP-ribose from poly(ADP-ribose) or O-acetyl-ADP-ribose by contacting with an isolated ARH3 polypeptide; modifying DNA repair or chromatin structure by modifying ARH3 polypeptide activity; drug screening; antiinflammatory, antiischemic agents; aging resistance |
| 08/28/2008 | US20080207548 Immunogenic polynucleotides, expression vectors, antigen presenting host cells, diagnostic kits; cancer vaccines |
| 08/28/2008 | US20080207547 Compositions and methods for the therapy and diagnosis of breast cancer |
| 08/28/2008 | US20080207539 Self-Processing Rna Expression Cassette |
| 08/28/2008 | US20080207532 Use of Nordihydroguaiaretic Acid Derivatives in the Treatment of Drug Resistant Cancer, Viral and Microbial Infection |
| 08/28/2008 | US20080207520 Tumor-associated Peptides Binding Promiscuously to Human Leukocyte Antigen (HLA) Class II Molecules |
| 08/28/2008 | US20080207517 SELECTIVE INHIBITION OF NF-kappaB ACTIVIATION BY PEPTIDES DESIGNED TO DISRUPT NEMO OLIGOMERIZATION |
| 08/28/2008 | US20080207510 Modified vitamin k-dependent polypeptides |
| 08/28/2008 | US20080207504 SECRETED FRIZZLED RELATED PROTEIN, sFRP, FRAGMENTS AND METHODS OF USE THEREOF |
| 08/28/2008 | US20080207502 Anti-Angiogenic Peptides and Methods of Use Thereof |
| 08/28/2008 | US20080207484 Polypeptides; hybrid nucleic acids; anticancer agents; central nervous system disorders |
| 08/28/2008 | US20080207459 Antibody diversity generation |
| 08/28/2008 | US20080207449 Polypeptides; antisense nucleic acids; gene expression vectors that have been inserted: transgenic plants; agriculture; diagnosis; screening; therapy |
| 08/28/2008 | US20080206871 transfecting skeletal muscle cells in vivo with nucleic acids encoding the proteins by electroporation; results in production of the desired protein on the order of about 2-3 magnitudes more as compared to standard methods, allowing for various biological uses including purification and crystallization |
| 08/28/2008 | US20080206869 modification of RNA or DNA molecules in order to add functions in terms of delivery and specificity to RNA interference or antisense technology |
| 08/28/2008 | US20080206868 storing conifer somatic embryo germinants germinated on a sterile germination medium for delayed transplanting into a growth medium |
| 08/28/2008 | US20080206867 Fc variants with optimized Fc receptor binding properties |
| 08/28/2008 | US20080206866 Reagency and Method for Preventing Time-Dependent Expression in Biological Cells |
| 08/28/2008 | US20080206865 Method of in vitro differentiation of neural stem cells, motor neurons and dopamine neurons from primate embryonic stem cells |
| 08/28/2008 | US20080206864 Methods and Materials for Culturing Murine Embryonic Stem Cells |
| 08/28/2008 | US20080206863 embryonic stem cell having been genetically engineered with DNA which encodes MyoD, which promotes differentiation of said embryonic stem cell into a muscle cell |